Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenotype modulators in myophosphorylase deficiency.

Andrea Martinuzzi1, Elena Sartori, Marina Fanin

  • 1E. Medea Scientific Institute, Conegliano Research Centre, Conegliano, Italy. andrea.martinuzzi@cn.lnf.it

Annals of Neurology
|April 1, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain health awareness among solid organ transplant candidates and recipients: a single centre survey.

BMC neurology·2026
Same author

Physicochemical Stability of Dentin-Derived Biomaterials During Long-Term Storage.

Journal of functional biomaterials·2026
Same author

Reply to: Effect of endoscopic pre-aponeurotic repair of diastasis recti on gastroesophageal reflux symptoms.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Ultrasound-guided percutaneous stellate ganglion block for refractory atrial fibrillation.

Minerva anestesiologica·2026
Same author

Percutaneous Stellate Ganglion Ablation as a Novel Bail-Out Strategy for Refractory Ventricular Arrhythmias: A Clinical Case Series.

JACC. Clinical electrophysiology·2026
Same author

A call for action to strengthen stakeholder readiness for ICF data exchange in European health data space: a structured narrative review.

Frontiers in public health·2026

Polymorphic variants in angiotensin-converting enzyme (ACE) significantly influence the severity of myophosphorylase deficiency, also known as McArdle's disease. This finding helps explain clinical variability in patients with this genetic muscle disorder.

Area of Science:

  • Exercise physiology
  • Human genetics
  • Biochemistry

Background:

  • Myophosphorylase deficiency (McArdle's disease) presents with variable clinical severity, including exercise intolerance, muscle cramps, and myoglobinuria.
  • The molecular basis of McArdle's disease is understood, but it doesn't fully explain the wide range of patient symptoms.
  • Genetic factors may modulate the clinical expression of McArdle's disease.

Purpose of the Study:

  • To investigate whether genetic polymorphisms in myoadenylate deaminase (MADA) or angiotensin-converting enzyme (ACE) influence the clinical severity of myophosphorylase deficiency.
  • To correlate MADA and ACE genotypes with disease severity in a cohort of patients with McArdle's disease.

Main Methods:

  • Evaluated 47 patients with myophosphorylase deficiency using a four-grade severity scale.

Related Experiment Videos

  • Assessed MADA activity via histochemical and biochemical muscle analysis.
  • Genetically analyzed the Q12X mutation in the AMPD1 gene and the ACE insertion/deletion polymorphism.

    • Main Results:

    • No significant association was found between MADA status and clinical grading.
    • A highly significant correlation (p < 0.01) was observed between ACE genotype and clinical severity.
    • Patients with a severe phenotype showed a strong correlation with the number of D alleles in the ACE gene.

    Conclusions:

    • The angiotensin-converting enzyme (ACE) insertion/deletion polymorphism acts as a significant phenotype modulator in McArdle's disease.
    • Genetic variations in ACE can explain some of the clinical variability observed in patients with myophosphorylase deficiency.